Skip to content

A clinical trail of Siddha drug MV Kashayam in Dengue positive patients

A Prospective randomized double arm open labelled comparative clinical trial to analyse the effectiveness of Siddha medicine MV kashayam vs standard conventional treatment among Dengue positive patients. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072099
Enrollment
80
Registered
2024-08-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 4- Measurement and Monitoring

Interventions

Intervention1: MV KASHAYAM: The kashayam has prepared as per siddha procedure given at the dose rate of 150 ml for every every six hours interval for the treatment period until recovery and study its

Sponsors

Gayathri
Lead Sponsor
MInistry of Health and family welfare Department
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients with a report of positive Dengue IgM test and platelet count less than 1.5 lakhs per cumm 2 The patients of either sex within the age group between the age group of 15 to 60 years Based on this triaging patients were admitted to the Government District Head Quarters Hospital Aruppukottai and somewhere given home quarantine. 3 Patients with mild and moderate symptoms of Dengue 4 Patients of both sexes and willing to accept the Siddha or standard conventional treatment method

Exclusion criteria

Exclusion criteria: 1 Dengue IgM negative patients and patients of less than 15 years of age and above 60 years of age 2 Patients with report of positive Dengue IgM test and platelet count more than 1.5 laks per cumm. 3 Pregnant and breastfeeding women 4 Patients with other systemic malignant diseases such as malignant tumors and mental illness 5 If the researchers consider that the patient is unsuitable for participation in the study 6 Patients have already taken Dengue treatment 7 Patient discharge against medical advice to Patients participating in other clinical trials

Design outcomes

Primary

MeasureTime frame
Clearance of symptoms and increased platelet count and decreased CRPTimepoint: 4 to 6 days or until till recovery

Secondary

MeasureTime frame
Even after Length of stay in hospitalization following patients were consider to have poor out come even then duration of hospital stay is less. Patients referred to higher center. Patients who were dead after receiving five days of our treatment.For following patients with less duration of hospital stay are consider to have good out come were discharged and referred to medical colleges under supervision.Timepoint: 4 to 10 days

Countries

India

Contacts

Public ContactDr P Dharumarajan

Government Head Quarters Hospital Aruppukottai

harsanasiddhamm@gmail.com9442581332

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026